Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies

• Asıl Yazarlar: Roberta Maria Antonello (Yazar), Luigi Principe (Yazar), Alberto Enrico Maraolo (Yazar), Valentina Viaggi (Yazar), Riccardo Pol (Yazar), Massimiliano Fabbiani (Yazar), Francesca Montagnani (Yazar), Antonio Lovecchio (Yazar), Roberto Luzzati (Yazar), Stefano Di Bella (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2020-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Fosfomycin is being increasingly prescribed for multidrug-resistant bacterial infections. In patients with systemic involvement, intravenous fosfomycin is usually administered as a partner drug, as part of an antibiotic regimen. Hence, the knowledge of fosfomycin pharmacodynamic interactions (synerg...